FY2024 EPS Estimate for Ascend Wellness Reduced by Analyst

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Investment analysts at Atb Cap Markets cut their FY2024 earnings estimates for Ascend Wellness in a research report issued on Tuesday, November 12th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.40) for the year, down from their previous forecast of ($0.32). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Atb Cap Markets also issued estimates for Ascend Wellness’ Q4 2024 earnings at ($0.08) EPS, FY2026 earnings at ($0.12) EPS, FY2027 earnings at ($0.11) EPS and FY2028 earnings at ($0.09) EPS.

Ascend Wellness (OTC:AAWH) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.03). Ascend Wellness had a negative return on equity of 66.28% and a negative net margin of 15.47%. The firm had revenue of $141.65 million for the quarter, compared to analysts’ expectations of $144.13 million.

Ascend Wellness Stock Performance

Shares of OTC:AAWH opened at $0.50 on Friday. The business’s 50 day moving average price is $0.83 and its 200-day moving average price is $0.96. Ascend Wellness has a 1 year low of $0.45 and a 1 year high of $1.82. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.29 and a quick ratio of 1.29. The firm has a market capitalization of $106.95 million, a PE ratio of -1.22 and a beta of 1.69.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.